Clinical Trials on Severe SARS-CoV2 Pneumonia in Argentina
Total 31 results
-
Hospital de Infecciosas Francisco Javier MunizCompletedCovid19 | SARS-CoV Infection | SARS-Associated CoronavirusArgentina
-
Ministry of Public Health, ArgentinaCompletedCovid19 | SARS (Severe Acute Respiratory Syndrome)Argentina
-
Maria de los Angeles Peral de BrunoCompletedCovid19 | SARS (Severe Acute Respiratory Syndrome)Argentina
-
Hospital Italiano de Buenos AiresCompletedCOVID-19 | SARS-CoV-2 | SARS VirusArgentina
-
Hospital de Clinicas José de San MartínSILVATEAMTerminatedCOVID-19 | Coronavirus Infection | SARS-CoV 2Argentina
-
Rigel PharmaceuticalsCompletedPneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS PneumoniaUnited States, Argentina, Brazil, Mexico
-
Ministerio de Salud de Ciudad Autónoma de Buenos...Completed
-
Hospital Italiano de Buenos AiresSociedad Argentina de Infectología (SADI) (Argentine Society of Infectious...UnknownCOVID-19 | Healthcare Workers | SARS-CoV 2Argentina
-
University of BolognaCharite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaboratorsRecruitingSARS CoV 2 Infection | Vaccination; Infection | Breakthrough InfectionArgentina, Gabon, India, Ireland, Italy, Luxembourg, Netherlands, Spain
-
Partner Therapeutics, Inc.United States Department of DefenseCompletedCovid19 | SARS-CoV InfectionUnited States, Argentina
-
Fundación HuéspedMinisterio de Salud de Ciudad Autónoma de Buenos Aires; Laboratorios Roemmers...RecruitingCovid19 | SARS-CoV-2 Infection | Households ContactsArgentina
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...CompletedSARS-CoV 2 | COVID | COVID19 | DyspneaUnited States, Argentina, Denmark, United Kingdom
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsRecruitingCovid19 | COVID | SARS-CoV2 InfectionUnited States, Spain, Argentina, Denmark, Greece, India, Mexico, Uganda
-
Nemechek TechnologiesCompletedSevere Acute Respiratory Syndrome Coronavirus 2Argentina
-
Hospital Italiano de Buenos AiresHospital de Niños R. Gutierrez de Buenos Aires; Salud Comunitaria Ministerio...Completed
-
Hospital Italiano de Buenos AiresRecruitingTocilizumab | Severe COVID 19 PneumoniaArgentina
-
Eurnekian Public HospitalCompletedSevere Acute Respiratory Syndrome | Ventilation PneumonitisArgentina
-
CureVacCompletedCovid19 | SARS-CoV-2Belgium, Spain, Germany, Argentina, Colombia, Dominican Republic, Mexico, Netherlands, Panama, Peru
-
COVID-19 Prevention NetworkNational Institute of Allergy and Infectious Diseases (NIAID)CompletedCOVID-19 | SARS-CoV-2United States, Malawi, Zimbabwe, Botswana, South Africa, Zambia, Argentina, Brazil, Mexico, Peru, Tanzania
-
Clinica San Camilo, ArgentinaUnknownPneumonia | Covid19Argentina
-
MedicagoActive, not recruitingSARS-CoV-2 InfectionUnited States, Canada, United Kingdom, Argentina, Brazil, Mexico
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...RecruitingInfluenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionUnited States, Germany, Turkey, South Africa, Argentina, Brazil
-
Atea Pharmaceuticals, Inc.Active, not recruitingCOVID-19 | SARS CoV 2 InfectionUnited States, Argentina, Brazil, Canada, Germany, India, Japan, Latvia, Mexico, Netherlands, Pakistan, Philippines, Romania, South Africa, Spain, Sweden, Tunisia, Turkey, United Kingdom
-
ShionogiNational Institute of Allergy and Infectious Diseases (NIAID)CompletedA Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)SARS-CoV-2 InfectionUnited States, India, Uganda, Poland, Philippines, Thailand, Pakistan, South Africa, Argentina, Brazil, Colombia, Ghana, Japan, Kenya, Malawi, Mexico, Turkey
-
Veru Inc.CompletedSARS-CoV InfectionUnited States, Argentina, Brazil, Bulgaria, Colombia, Mexico
-
University of ChileColumbia UniversityRecruitingDepression | Covid-19 | Anxiety | Mental Health Disorder | SARS-CoV-2 | Stress DisorderUnited States, Italy, Argentina, Armenia, Australia, Bolivia, Chile, Costa Rica, Czechia, Germany, Guatemala, Lebanon, Mexico, Netherlands, Nigeria, Puerto Rico, Saudi Arabia, Spain, Tunisia, Turkey, Venezuela
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
Dompé Farmaceutici S.p.ARecruitingSevere COVID-19 | Infectious PneumoniaUnited States, Australia, Turkey, Argentina, Germany, Austria, Italy
-
GlaxoSmithKlineCompletedSevere Acute Respiratory SyndromeUnited States, Russian Federation, Peru, Netherlands, Spain, South Africa, United Kingdom, Argentina, Brazil, France, Canada, Mexico, Poland, Belgium, India, Japan, Chile, Colombia, Italy
-
Janssen Vaccines & Prevention B.V.CompletedParticipants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the ProtocolUnited States, Mexico, South Africa, Brazil, Chile, Colombia, Peru, Argentina